The Zacks Analyst Blog Highlights: AbbVie, Merck, Eli Lilly, Novartis and Pfizer

Published on February 7, 2022

AbbVie, Merck, Eli Lilly, Novartis and Pfizer are included in this analyst blog.

Continue reading on website
Other news

Here's Why You Should Add Quidel (QDEL) Stock To Your Portfolio

February 7, 2022
Investors continue to be optimistic about Quidel (QDEL) owing to its strong diagnostics portfolio.

Comcast vs. ViacomCBS: Which Stock is a Better Buy for 2022?

February 7, 2022
The entertainment industry is growing rapidly, with surging demand for over-the-top (OTT) content and other services. Therefore, prominent industry participants Comcast (CMCSA) and ViacomCBS (VIAC) should benefit. But which of...